Effects of Soft Tissue Mobilization on Postsurgical Adhesions, Pain, Lumbopelvic Muscle Functions, Spinal Mobility, and Posture in Postpartum Women With Caesarean Section

May 20, 2025 updated by: YI-JU TSAI
Postpartum women with C-section receiving deep and superficial tissue mobilization would have better improvement on pain, lumbopelvic muscle functions, spinal mobility, and posture compare to the superficial tissue mobilization and control group

Study Overview

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tainan, Taiwan, 701
        • National Cheng Kung University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

vaginal delivery

Inclusion Criteria:

  • Natural birth without C-section scar
  • Postpartum more than 6 months
  • Without any pain in the lumbopelvic region

C-section

Inclusion Criteria:

  • Healed C-section scar > six months
  • Scar with or without pain

Both mode of delivery

Exclusion Criteria:

  • Active infection or infectious disease in the pelvis or abdomen
  • Pain medications on days of measurements
  • Skin irritation and inflammation at the site of the scar
  • Currently pregnant or actively trying to get pregnant
  • History of radiation to the area
  • Any fracture around spine and pelvis
  • Any previous gynecologic and obstetric surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: deep and superficial tissue mobilization group
include deep and superficial tissue mobilization
Myofascial abdominal diaphragm release
Direct focused scar release technique
Direct manipulations to visceral structures
pelvic anatomy education
Active Comparator: superficial tissue mobilization group
superficial tissue mobilization
Myofascial abdominal diaphragm release
Direct focused scar release technique
Placebo Comparator: control group
Sham (very light hand touch on the same location as the other two groups but without any treatment intention)
pelvic anatomy education
sham
Other: vaginal delivery group
education session
pelvic anatomy education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scar Characteristic: Extensibility
Time Frame: 8 weeks
The extensibility of the scar will be measured using the modified adheremeter in each of 4 directions including superior, inferior, medial and lateral and then the area of mobility will be calculated.
8 weeks
Scar Characteristic: Viscoelasticity
Time Frame: 8 weeks
The biomechanical and viscoelastic properties of the scar tissue will be measured using a non-invasive myometer
8 weeks
Scar Characteristic: Irritability
Time Frame: 8 weeks
The irritability of the scar will be measured using the digital pressure algometer for two conditions: first, when the pressure turns from discomfort to pain and the participant asks to stop, and then when the maximal pressure or pain the participant can tolerate.
8 weeks
Muscle function measures of lumbopelvic muscles
Time Frame: 8 weeks
Ultrasonography image for muscle thickness of lumbopelvic muscles during rest and maximum contraction.
8 weeks
Muscle function measures of pelvic floor muscle control
Time Frame: 8 weeks
Ultrasonography image for muscle thickness of pelvic floor muscle control during rest, maximum contraction
8 weeks
Spinal Mobility
Time Frame: 8 weeks
Range of motion for cervical, thoracic, and lumbar spine in the sagittal, frontal, and transverse plane as well as pelvic tilt will be assessed using the wireless double inclinometers
8 weeks
Myofascial Flexibility
Time Frame: 8 weeks
Straight leg raise test and Thomas test will be used to examine the muscle flexibility of the major lower extremity muscles.
8 weeks
Spinal Alignment and Posture
Time Frame: 8 weeks
Radiographic measurement, posture will be assessed using the photographic measurement. Reflective markers will first be placed and attached on the canthus of the eye, tragus of the ear, the spinous processes of C2, C7, T1, T3, T11, T12, L1, L5, S1, S5, and bilateral anterior superior iliac spine and posterior superior iliac spine in standing. The participants will be instructed to maintain their gaze straight ahead at a target adjusted for body height. Two standing photographs will be taken, one in the usual standing posture and the other in the best standing posture. Following the other two photographs will be taken, one in maximal pelvic anterior tilt and the other in the maximal pelvic posterior tilt.
8 weeks
Pain intensity measure of Visual Analogue Scale
Time Frame: 8 weeks
Visual Analogue Scale is a self-reported instrument assessing average pain intensity in currently. Possible score range from 0 (no pain) to 10 (worst possible pain).
8 weeks
Pain intensity measure of pelvic girdle questionnaire
Time Frame: 8 weeks
pelvic girdle questionnaire is a self-reported instrument assessing pelvic girdle pain intensity in currently. Questionnaire consisting of 20 activity items and 5 symptom items on a 4-point response scale. Possible score range from 0 (no pain) to 100 (worst possible pain).
8 weeks
Pain intensity measure of Oswestry Low Back Pain Disability Questionnaire
Time Frame: 8 weeks
Oswestry Low Back Pain Disability Questionnaire is a self-reported instrument assessing patient's permanent functional disability in currently. For each section the total possible score is 5: if the first statement is marked the section score = 0; if the last statement is marked, it = 5. The higher the score, the greater the degree of disability.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-perceived Change Health Status: Global Rating of Change Scale (GROC)
Time Frame: 8 weeks
The GROC is a single-item instrument that provides a means of measuring self-perceived change in health status. The GROC uses the 15-point Likert scale to rate the perceived "overall change" on a continuum, with -7 (labeled "worse") on the left and +7 (labeled "better") on the right, and 0 in the middle (labeled "no change"), compared with the baseline
8 weeks
Patient and Observer Scar Assessment Scale (POSAS)
Time Frame: 8 weeks
The POSAS includes 2 numerical numeric scales: The Patient Scar Assessment Scale and the Observer Scar Assessment Scale. It objectively assesses vascularity, pigmentation, thickness, relief, pliability, and surface area, and incorporates patient subjective symptoms of pain, itching, color, stiffness, thickness, and relief.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 8, 2023

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

August 10, 2021

First Submitted That Met QC Criteria

August 10, 2021

First Posted (Actual)

August 17, 2021

Study Record Updates

Last Update Posted (Actual)

May 23, 2025

Last Update Submitted That Met QC Criteria

May 20, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NCKU_adhesion

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postsurgical Adhesion

Clinical Trials on Myofascial abdominal diaphragm release

Subscribe